ClariTrial | Search Clinical Trials

Explore/Cancer

Status

Phase

145,103 results for “Cancer”

Page 1 of 9674

Completed

Effect Inverse Ratio Ventilation on Arterial Oxygenation and Respiratory Mechanics During lapaLAR

N/AColorectal Neoplasms

inverse IE

Gachon University Gil Medical Center30 participants1 site · South KoreaCompletes Dec 2014

Compare CT.gov Full analysis →

Completed

Results posted

A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia

Phase 2Acute Myeloid Leukemia

ASLAN003

ASLAN Pharmaceuticals24 participants8 sites · United States, Australia, SingaporeCompletes Sep 2019

Compare CT.gov Full analysis →

Completed

Results posted

Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer

Phase 1Phase 2Metastatic Breast Cancer

DasatinibIxabepilone

Accelerated Community Oncology Research Network56 participants13 sites · United StatesCompletes Oct 2013

Compare CT.gov Full analysis →

Active

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

Phase 2Phase 3Non-Small Cell Lung Cancer

AlectinibAtezolizumabPemetrexed+9 more

Hoffmann-La Roche1,000 participants161 sites · United States, Argentina, AustraliaCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients

N/ACancer of BreastCancer Colon

ONS Pre-op + ONS Post-opONS Pre-op + ONS Post-op + ONS Post-op 3 monthsUsual intake Pre-op + ONS Post-op

IMU University, Malaysia91 participants1 site · MalaysiaCompletes Jun 2021

Compare CT.gov Full analysis →

Completed

Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

N/ARenal Cell Carcinoma Stage IV

mHealth Smart Phone ApplicationeHEALS digital literacy testWeekly Quiz+2 more

H. Lee Moffitt Cancer Center and Research Institute20 participants1 site · United StatesCompletes Jan 2024

Compare CT.gov Full analysis →

Completed

Nonpharmacological Approaches and Parental Education in Children With Sickle Cell Disease

N/ANursing Caries

nonpharmacological approaches to parents of children with sickle cell disease training program

Akdeniz University163 participants1 site · Turkey (Türkiye)Completes Feb 2016

Compare CT.gov Full analysis →

UNKNOWN

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

Phase 1Phase 2Breast Cancer

SHR-A1811 for injection ; capecitabine

Suzhou Suncadia Biopharmaceuticals Co., Ltd.116 participants9 sites · ChinaCompletes Dec 2024

Compare CT.gov Full analysis →

Completed

Impact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort Study

N/ACongenital Heart Disease (CHD)Hematologic Malignancy

Children's Hospital of Fudan University800 participants18 sites · ChinaCompletes Nov 2025

Compare CT.gov Full analysis →

Completed

Palliative and Oncology Care Model in Breast Cancer

N/AMetastatic Breast Cancer

Palliative and Oncology CareStandard Oncology Care

Massachusetts General Hospital120 participants1 site · United StatesCompletes Sep 2019

Compare CT.gov Full analysis →

Recruiting

DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer

Phase 3Older PatientsColorectal CancerMetastatic Cancer

Doublet Chemotherapy, Standard Dose (100%)Doublet Chemotherapy, Dose-reduced (75%)Monotherapy, Standard Dose (100%)+1 more

Leiden University Medical Center587 participants36 sites · NetherlandsCompletes Jun 2028

Compare CT.gov Full analysis →

Withdrawn

ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia

Phase 2Warm Autoimmune Hemolytic Anemia

ALXN1830Placebo

Alexion Pharmaceuticals, Inc.01 site · United StatesCompletes Oct 2022

Compare CT.gov Full analysis →

Not Yet Recruiting

Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas

Phase 2Diffuse Large B Cell Lymphoma Refractory

Glofitamab

American University of Beirut Medical Center40 participantsCompletes Dec 2031

Compare CT.gov Full analysis →

Not Yet Recruiting

Translation and Validation of the Hypoparathyroidism Patient Experience Scales (HPES) Questionnaire in Greek

N/AHypoparathyroidism

Questionnaire and Physical Exam

Aristotle University Of Thessaloniki200 participantsCompletes Apr 2026

Compare CT.gov Full analysis →

Completed

Results posted

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Phase 4Refractory Cutaneous T-cell Lymphoma

Bexarotene

Bausch Health Americas, Inc.59 participants17 sites · United StatesCompletes Feb 2014

Compare CT.gov Full analysis →

1–15 of 145,103

Explore/Cancer

Status

Phase

145,103 results for “Cancer”

Page 1 of 9674

Completed

Effect Inverse Ratio Ventilation on Arterial Oxygenation and Respiratory Mechanics During lapaLAR

N/AColorectal Neoplasms

inverse IE

Gachon University Gil Medical Center30 participants1 site · South KoreaCompletes Dec 2014

Compare CT.gov Full analysis →

Completed

Results posted

A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia

Phase 2Acute Myeloid Leukemia

ASLAN003

ASLAN Pharmaceuticals24 participants8 sites · United States, Australia, SingaporeCompletes Sep 2019

Compare CT.gov Full analysis →

Completed

Results posted

Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer

Phase 1Phase 2Metastatic Breast Cancer

DasatinibIxabepilone

Accelerated Community Oncology Research Network56 participants13 sites · United StatesCompletes Oct 2013

Compare CT.gov Full analysis →

Active

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

Phase 2Phase 3Non-Small Cell Lung Cancer

AlectinibAtezolizumabPemetrexed+9 more

Hoffmann-La Roche1,000 participants161 sites · United States, Argentina, AustraliaCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients

N/ACancer of BreastCancer Colon

ONS Pre-op + ONS Post-opONS Pre-op + ONS Post-op + ONS Post-op 3 monthsUsual intake Pre-op + ONS Post-op

IMU University, Malaysia91 participants1 site · MalaysiaCompletes Jun 2021

Compare CT.gov Full analysis →

Completed

Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

N/ARenal Cell Carcinoma Stage IV

mHealth Smart Phone ApplicationeHEALS digital literacy testWeekly Quiz+2 more

H. Lee Moffitt Cancer Center and Research Institute20 participants1 site · United StatesCompletes Jan 2024

Compare CT.gov Full analysis →

Completed

Nonpharmacological Approaches and Parental Education in Children With Sickle Cell Disease

N/ANursing Caries

nonpharmacological approaches to parents of children with sickle cell disease training program

Akdeniz University163 participants1 site · Turkey (Türkiye)Completes Feb 2016

Compare CT.gov Full analysis →

UNKNOWN

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

Phase 1Phase 2Breast Cancer

SHR-A1811 for injection ; capecitabine

Suzhou Suncadia Biopharmaceuticals Co., Ltd.116 participants9 sites · ChinaCompletes Dec 2024

Compare CT.gov Full analysis →

Completed

Impact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort Study

N/ACongenital Heart Disease (CHD)Hematologic Malignancy

Children's Hospital of Fudan University800 participants18 sites · ChinaCompletes Nov 2025

Compare CT.gov Full analysis →

Completed

Palliative and Oncology Care Model in Breast Cancer

N/AMetastatic Breast Cancer

Palliative and Oncology CareStandard Oncology Care

Massachusetts General Hospital120 participants1 site · United StatesCompletes Sep 2019

Compare CT.gov Full analysis →

Recruiting

DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer

Phase 3Older PatientsColorectal CancerMetastatic Cancer

Doublet Chemotherapy, Standard Dose (100%)Doublet Chemotherapy, Dose-reduced (75%)Monotherapy, Standard Dose (100%)+1 more

Leiden University Medical Center587 participants36 sites · NetherlandsCompletes Jun 2028

Compare CT.gov Full analysis →

Withdrawn

ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia

Phase 2Warm Autoimmune Hemolytic Anemia

ALXN1830Placebo

Alexion Pharmaceuticals, Inc.01 site · United StatesCompletes Oct 2022

Compare CT.gov Full analysis →

Not Yet Recruiting

Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas

Phase 2Diffuse Large B Cell Lymphoma Refractory

Glofitamab

American University of Beirut Medical Center40 participantsCompletes Dec 2031

Compare CT.gov Full analysis →

Not Yet Recruiting

Translation and Validation of the Hypoparathyroidism Patient Experience Scales (HPES) Questionnaire in Greek

N/AHypoparathyroidism

Questionnaire and Physical Exam

Aristotle University Of Thessaloniki200 participantsCompletes Apr 2026

Compare CT.gov Full analysis →

Completed

Results posted

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Phase 4Refractory Cutaneous T-cell Lymphoma

Bexarotene

Bausch Health Americas, Inc.59 participants17 sites · United StatesCompletes Feb 2014

Compare CT.gov Full analysis →

1–15 of 145,103